about
Herpesvirus telomeric repeats facilitate genomic integration into host telomeres and mobilization of viral DNA during reactivationThe molecular biology of human herpesvirus-6 latency and telomere integrationMicroRNA profile of Marek's disease virus-transformed T-cell line MSB-1: predominance of virus-encoded microRNAsEmerging Roles of Herpesvirus microRNAs During In Vivo Infection and PathogenesisVirus meets host microRNA: the destroyer, the booster, the hijackerVirus and host genomic, molecular, and cellular interactions during Marek's disease pathogenesis and oncogenesisInteraction domain of glycoproteins gB and gH of Marek's disease virus and identification of an antiviral peptide with dual functionsComparative study of tumorigenesis and tumor immunity in invertebrates and nonmammalian vertebratesMarek's disease virus type 2 (MDV-2)-encoded microRNAs show no sequence conservation with those encoded by MDV-1.Co-Infection with Marek's Disease Virus and Reticuloendotheliosis Virus Increases Illness Severity and Reduces Marek's Disease Vaccine Efficacy.A Chinese Variant Marek's Disease Virus Strain with Divergence between Virulence and Vaccine Resistance.Marek's disease virus and skin interactions.Acute paretic syndrome in juvenile White Leghorn chickens resembles late stages of acute inflammatory demyelinating polyneuropathies in humans.Herpesvirus telomerase RNA(vTR)-dependent lymphoma formation does not require interaction of vTR with telomerase reverse transcriptase (TERT).Alternative splicing and nonsense-mediated decay regulate telomerase reverse transcriptase (TERT) expression during virus-induced lymphomagenesis in vivoCharacterization of Copy Number Variation's Potential Role in Marek's DiseaseCytogenetic stability of chicken T-cell line transformed with Marek's disease virus: atomic force microscope, a new tool for investigation.Viral control of vTR expression is critical for efficient formation and dissemination of lymphoma induced by Marek's disease virus (MDV).Imperfect Vaccination Can Enhance the Transmission of Highly Virulent PathogensHerpesvirus telomerase RNA (vTR) with a mutated template sequence abrogates herpesvirus-induced lymphomagenesis.A novel herpesvirus in 3 species of pheasants: mountain peacock pheasant (Polyplectron inopinatum), Malayan peacock pheasant (Polyplectron malacense), and Congo peafowl (Afropavo congensis).Modelling Marek's disease virus (MDV) infection: parameter estimates for mortality rate and infectiousnessA p53-dependent promoter associated with polymorphic tandem repeats controls the expression of a viral transcript encoding clustered microRNAsA virulent bioluminescent and fluorescent dual-reporter Marek's disease virus unveils an alternative spreading pathway in addition to cell-to-cell contact.Dual infection and superinfection inhibition of epithelial skin cells by two alphaherpesviruses co-occur in the natural host.Direct detection of Marek's disease virus in poultry dust by loop-mediated isothermal amplification.Marek's disease virus infection induces widespread differential chromatin marks in inbred chicken lines.Marek's disease virus type 1 microRNA miR-M3 suppresses cisplatin-induced apoptosis by targeting Smad2 of the transforming growth factor beta signal pathway.Chromosomal integration of an avian oncogenic herpesvirus reveals telomeric preferences and evidence for lymphoma clonality.Structural characteristics and antiviral activity of multiple peptides derived from MDV glycoproteins B and HFrequency of chromosomally-integrated human herpesvirus 6 in children with acute lymphoblastic leukemia.In vivo expression patterns of microRNAs of Gallid herpesvirus 2 (GaHV-2) during the virus life cycle and development of Marek's disease lymphomas.Poly(A) binding protein 1 enhances cap-independent translation initiation of neurovirulence factor from avian herpesvirus.In vitro model for lytic replication, latency, and transformation of an oncogenic alphaherpesvirus.The Need for Evolutionarily Rational Disease Interventions: Vaccination Can Select for Higher VirulenceFine mapping of QTL and genomic prediction using allele-specific expression SNPs demonstrates that the complex trait of genetic resistance to Marek's disease is predominantly determined by transcriptional regulation.Genome-wide identification of copy number variations between two chicken lines that differ in genetic resistance to Marek's disease.Inherited chromosomally integrated human herpesvirus 6 as a predisposing risk factor for the development of angina pectoris.Horizontal transmission of Marek's disease virus requires US2, the UL13 protein kinase, and gCPositive Selection Drives Rapid Evolution of the meq Oncogene of Marek's Disease Virus
P2860
Q24596192-3F1B84B1-4BF4-48B9-AAB6-3895BA986021Q24596930-66F2C05B-C9F7-4BCF-906A-7E85BEDF8077Q24655611-AAB8BD06-C1C1-4B3D-9C81-6634B833DB46Q26801624-3A28D656-72CB-413E-BC92-7ED7442E624AQ27028188-A2C72720-20A2-4497-808A-B7A38D8E423BQ28075941-3DECA030-2A23-45E7-BA1E-10C8DB3DECD9Q28486009-9FB8CE9A-2B99-4964-9DAA-1F6D17A6D6D6Q28750443-2AAB07DC-A4D7-4B50-8514-79BED7694B68Q30831276-939C3FD6-A85B-4C05-A2FC-7C00EE8E3422Q32182863-59DB1058-FEE7-4156-A81B-026C8A054B53Q33613511-9ACC467F-9E88-42B1-A1EE-429F2603B229Q33646255-40D229AA-5FE6-4A60-AF1B-22C9E2AC5933Q33672114-45628857-E1F2-47B6-BAA9-4CEFA2C091FBQ33701712-A7909FC4-C1E2-4AD9-A480-EBDF731F4DF6Q33724680-90974AB4-D8A9-40F5-BB7A-03A36B77A756Q33755178-99A73CA9-B0EE-434F-B12B-51BD7B544AAEQ33864923-4DA84AAC-40AE-45A1-97C9-0B3C26FB2C33Q33896387-ADF0FCEC-F035-4080-B3E6-89566794E34FQ34044564-D7A7B974-27CB-4D94-AAD5-540775273548Q34064216-5E1C0883-806C-4541-8D20-AF458BC104D1Q34072555-D3C0A4C6-56F3-4070-83CC-AC8E1096546BQ34073274-AD8F6641-9325-422F-98A9-98978BDF4B37Q34210459-5E4DB46B-D67E-4475-ACB8-933A9D4F7A86Q34261802-740F9FC0-E20F-4B3F-B876-7D901F37D52BQ34281878-99A6A4BF-33BE-44CC-9646-C5F8D4BF88E0Q34356380-C7883EAE-ABAC-414E-8C54-0046C84A6469Q34448456-E71F04C3-3A9F-40E1-9FB4-FA9117F25BEEQ34457896-EB0D2EB4-7C49-4C51-BF37-31A427796849Q34712917-94412443-44C8-47A1-A45C-1CBE91462C32Q35042295-B9F04ABB-95C5-4839-AC67-09368E58D343Q35080910-CEE67C34-7C98-4896-91ED-1A91A19B04F1Q35236997-9C882F8F-CAC3-461F-A901-5F81180F4660Q35517170-22B479D5-7D85-447A-86DD-7F55ACB7616AQ35740347-49311DA5-65F7-4718-84C0-21203BE3C7C1Q35754769-7E55CC13-DA4B-4D44-9DB8-FD3DA77FB734Q35813288-C353C53B-EA08-4BF1-BB02-B5024F18EF89Q35817591-4F592485-F556-4CEB-97C5-82CE92B087CAQ35818622-2CD93D65-9777-4796-BA94-F05395200EF4Q36099059-9EB9C42B-A315-4576-994B-F930A5610EC7Q36143126-BAC5EC73-EFD7-4167-894A-50A1512F6619
P2860
description
2006 nî lūn-bûn
@nan
2006 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Marek's disease virus: from miasma to model.
@ast
Marek's disease virus: from miasma to model.
@en
type
label
Marek's disease virus: from miasma to model.
@ast
Marek's disease virus: from miasma to model.
@en
prefLabel
Marek's disease virus: from miasma to model.
@ast
Marek's disease virus: from miasma to model.
@en
P2093
P2860
P356
P1476
Marek's disease virus: from miasma to model.
@en
P2093
B Karsten Tischer
Daniel Schumacher
Jeremy P Kamil
Sascha Trapp
P2860
P2888
P304
P356
10.1038/NRMICRO1382
P407
P577
2006-04-01T00:00:00Z
P6179
1049255354